Riskpilot← Back to searchSign inGet full accessLAMBERTSETER LEGESENTER AS
ASActiveOrg 914802946Mellombølgen 47, 1157 OsloGeneral medical practice activities · NACE 8621Est. 20156 employees
Revenue 2024
NOK 5,2M
0% vs 2023
EBITDA margin
1.2%
-65% vs 2023
Equity ratio
34.3%
Financial strength
Net profit 2024
NOK -36K
-127% vs 2023
| Revenue | NOK 5,2M | +0% |
| EBITDA | NOK 64K | -65% |
| Net profit | NOK -36K | -127% |
| Total assets | NOK 1,4M | -17% |
| Equity | NOK 489K | -7% |
| Employees | 6 | — |
Legal name
LAMBERTSETER LEGESENTER AS
Org number
914802946
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
15. januar 2015
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Allmennlegevirksomhet i oslo kommune, deltakelse i andre selskaper, samt alt annet som naturlig faller inn under dette.
Address
Mellombølgen 47, 1157 Oslo
Phone
+4722749050
Email
lambertsetersenter@obos.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 726 | 4 758 | 5 315 | 5 198 | 5 188 |
| Staff expenses | −2 265 | −2 413 | −2 478 | −2 643 | −2 768 |
| EBITDA | 249 | −185 | 456 | 187 | 64 |
| Depreciation & amort. | −8 | −68 | −37 | −9 | −97 |
| EBIT | 241 | −253 | 419 | 178 | −33 |
| Net financials | −43 | −26 | −22 | −12 | −0 |
| Profit before tax | 198 | −279 | 397 | 166 | −33 |
| Tax | 42 | −0 | 32 | 32 | 4 |
| Net profit | 155 | −279 | 364 | 134 | −36 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 392 | 1 807 | 1 829 | 1 725 | 1 423 |
| Equity | 305 | 27 | 391 | 525 | 489 |
| Long-term debt | 918 | 582 | 245 | 0 | 0 |
| Short-term debt | 1 168 | 1 199 | 1 193 | 1 200 | 934 |
| Total debt | 2 087 | 1 781 | 1 438 | 1 200 | 934 |
EBITDA margin
1.2%
This company
15.8%
Market median
-92% vs market
20202024
Equity ratio
34.3%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
-7.4%
This company
18.4%
Market median
-140% vs market
20202024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20202024
Asset turnover
3.65×
This company
1.12×
Market median
+226% vs market
20202024
Debt / equity
1.91×
This company
0.62×
Market median
-208% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LAMBERTSETER LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|